Motor impairments are a major cause of morbidity and disability after stroke. This article reviews evidence obtained using transcranial magnetic stimulation (TMS) that provides new insight into mechanisms of impaired motor control and disability. They briefly discuss the use of TMS in the diagnosis, prognosis, and therapy of poststroke motor disability. Particular emphasis is placed on TMS as a tool to explore mechanisms of neuroplasticity during spontaneous and treatment-induced recovery of motor function to develop more rational and clinically useful interventions for stroke rehabilitation.
Introduction
Stroke continues to be the leading cause of long-term disability in the United States. 1 Primarily because of a loss of motor abilities and subsequent impairment in activities of daily living, stroke is estimated to cost the United States more than 2 trillion dollars in the next 50 years. 2 These economic and social costs are not restricted to the intensive acute care that occurs with stroke but rather are outweighed by later outpatient costs and are highly correlated with the level of disability. 3 Taken together, these statistics emphasize the need for interventions designed to improve poststroke neurorehabilitation. 4 Although recent advances in stroke care have primarily been concentrated on the neuroprotective and neurovascular fronts, 5, 6 tools used to study and alter cortical function have played a significant role in all parts of poststroke care: diagnostic, prognostic, and interventional. In this review, we will examine how transcranial magnetic stimulation (TMS) can be used to dissect the physiological mechanisms underlying motor deficits, spontaneous motor recovery, and the beneficial effects of therapeutic interventions. An understanding of these neurobiological foundations will likely enhance our abilities to diagnose, prognosticate, and treat poststroke motor disabilities.
TMS as a Technical Tool
Since the first reported use of TMS in humans, 7 it has been clear that this tool would enhance understanding of the nervous system and find application in medical treatment of nervous system disorders. Working via the principles of electromagnetic induction, standard TMS instruments consist of a high-voltage capacitor that can be discharged through an insulated coil of wires. [8] [9] [10] The rapid, time-varying magnetic field created around the coil, which passes unchanged through electrically resistant structures such as the skull, induces an electrical current in human brain tissue. When a TMS coil is placed on the scalp over the primary motor cortex (M1), the induced electrical current stimulates the neurons of the cortex. 11 When first applied to stroke patients, TMS was envisioned as a less painful alternative to transcranial electrical stimulation for the assessment of the impaired corticomotoneuronal pathways 12 ; however, it soon became clear that fundamental differences in the physiological effects of TMS compared with electrical stimulation could allow more elaborate investigations. 13, 14 Electrophysiological Measurements Available With TMS the cortex significantly affect its consequences and its uses. Generally, when TMS pulses are delivered at frequencies less than 0.3 Hz, it is for measurement purposes and has not been found to alter motor cortical excitability for prolonged periods of time as long as the motor system is at rest at the time of stimulus delivery. 15, 16 However, TMS stimuli applied to resting M1 at or above 0.3 Hz 17 and paired pulses 1.5 ms apart given in trains of at least 0.2 Hz 18 have been found to alter cortical excitability beyond the period of stimulation. All these and other forms of repetitive TMS (rTMS) can be used in an interventional manner to purposely alter cortical excitability, both in facilitatory and inhibitory ways, in an attempt to change the function of the underlying stimulated cortical tissues. The following represent some of the most common TMS measures used after stroke to dissect the physiological mechanisms underlying motor deficits, spontaneous motor recovery, and the beneficial effects of therapeutic interventions.
Motor evoked potentials (MEP).
When TMS is applied at intensities above motor threshold, the activation of excitatory interneurons can result in volleys of upper motor neuron activity, which subsequently activate a motor neurons of the spinal cord. The summed activity, an MEP, is measured via electromyography (EMG) from surface or needle electrodes over or in the muscles of interest 19 or as descending volleys of direct (D) or indirect (I) waves recorded from epidural electrodes over the spinal cord, close to the pyramidal tract. 20, 21 The amplitude, area under the curve, and latency of MEPs are all used in various ways to measure motor cortical excitability.
Resting motor threshold (rMT). This is defined as the intensity of stimulation required to produce an MEP of small amplitude in 5 out of 10 trials. 19 Stimulating M1 at different stimulus intensities (relative to rMT intensity or maximum stimulator output) creates an input/output or recruitment curve of MEP amplitudes 22, 23 that is usually sigmoidal in shape. rMT is predominantly influenced by mechanisms of neuronal membrane excitability, evidenced by its alteration in the presence of pharmacological modifiers of sodium and calcium channels and relative stability in the presence of modifiers of synaptic transmission. [24] [25] [26] rMT also correlates with measures of white matter microstructure. 27 In contrast, changes in synaptic excitability contribute to recruitment, as evidenced by their alteration in the presence of pharmacological modifiers of synaptic transmission.
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Short-interval intracortical inhibition (SICI) and facilitation (SICF) . Exploiting TMS's preferential activation of interneurons and transsynaptic activation of pyramidal tract cells has allowed for a better characterization of inhibitory and facilitatory mechanisms operating within M1. Paired pulse stimulation delivered through the same magnetic coil over M1, where a suprathreshold test stimulus (TS) is preceded by a subthreshold or suprathreshold conditioning stimulus (CS), can be used to gain insight into the relative contribution of local inhibitory and excitatory inputs to M1 pyramidal tract cells. The CS can cause an increase in MEP amplitude (facilitation, SICF) or decrease in MEP amplitude (inhibition, SICI) compared with the MEP evoked by the TS alone. Interstimulus intervals of approximately 1.5 to 3 milliseconds cause attenuation of MEP amplitudes or SICI, 29 which seems to be at least partially GABA-A receptor-mediated. 21, [30] [31] [32] [33] With longer interstimulus intervals (~6-10 milliseconds), it is possible to observe a facilitation of MEP amplitudes, referred to as SICF, 34 a more heterogeneous measurement that may have a significant spinal component. 35 One additional measurement that has been proposed as useful has been the determination of recruitment curves of SICI, a method that is perhaps underused but is likely to attract more attention in the future. 36, 37 Of additional interest is the fact that more pure measurements of intracortical inhibition are obtained when the intensity of the CS is under active motor threshold levels. 30 
Contralateral cortical silent period (CSP).
Another test of intracortical inhibition is the contralateral CSP, a drop in background voluntary EMG activity, which occurs when a suprathreshold TMS pulse is delivered to the M1 contralateral to a muscle that is voluntarily activated. It has been proposed that the later part of the contralateral CSP 38 is a GABA-B receptor-mediated cortical phenomenon 24 and hence likely represents a separate inhibitory network or mechanism within M1 relative to SICI. 30 
Interhemispheric inhibition (IHI).
The inhibitory interactions between the 2 M1s can be evaluated using a paired pulse technique, 39 where a suprathreshold CS is applied over the conditioning M1 at about 10 milliseconds prior to the TS applied to the opposite conditioned M1. Although other interstimulus intervals have been used, the 10-milliseconds interval has been the most widely studied (IHI 10 ). IHI 10 is likely mediated via transcallosal glutamatergic neurons from the conditioning M1 interacting with local GABA-B receptor-mediated inhibitory interneurons within the target M1. 40, 41 Another method of measuring IHI is the ipsilateral CSP, evidenced as the suppression of voluntary EMG activity in one muscle via ipsilateral M1 stimulation. 39, [42] [43] [44] Although both IHI 10 and ipsilateral CSP are forms of transcallosal inhibition, they are likely mediated by different subsets of transcallosal neurons and different interactions with local inhibitory circuits as evidenced by the lack of correlation in input/output curves between the 2 measures. Also, the current direction of the CS influences the level of ipsilateral CSP induced, unlike IHI 10 . 44, 45 Whereas both can be considered complementary measurements, ipsilateral CSP can be especially useful in stroke patients who may not have measurable MEPs in the paretic limb after stimulation of the ipsilesional M1 but can produce voluntary EMG activity. Measures of ipsilateral CSP in the paretic limb can reveal the level of transcallosal inhibition targeting ipsilesional M1. 46 Interregional interactions. Paired pulse and rTMS methods have also been used to evaluate the influence of nonprimary motor areas within the same and opposite hemispheres on M1, including dorsal premotor (PMd), [47] [48] [49] [50] [51] [52] [53] supplementary motor, 47, 54 parietal, 55 and cerebellar areas.
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Motor mapping. A cortical map of a target muscle's representation can be rendered by measuring MEP amplitudes evoked in that target muscle by TMS applied to different scalp positions [61] [62] [63] [64] ; by weighting each point by some measure of the overall map, a center of gravity for a particular muscle representation can also be determined. Motor mapping using TMS has some similarities with mapping using functional neuroimaging in that the size of the map depends to some extent on the intensity of stimulation used and in that an increase in map size may be a result of either increased excitability of an unchanged cortical representation or of an actual centrifugal increase in motor map size. 65 Alternatively, motor maps may show well-characterized topographic displacement of the center of gravity, as for example, what occurs after amputation, where a nearby representation expands consistently over the deafferented representation, 66 indicating real representational plasticity.
Central motor conduction (CMC). The latency of MEP onsets can be used to measure nervous system conduction time. When peripheral conduction time is also known, via magnetic stimulation of the cervical roots or F-wave testing, then a CMC time can be calculated. 67, 68 Abnormalities in CMC time may be a result of axonal or demyelinating lesions of the corticospinal tract.
This brief introduction is intended to define some of the most common TMS measurements and their proposed mechanisms as they have been applied across healthy volunteers and poststroke populations. 33 Overall, these techniques allow detailed analysis at various levels of interactions within and across cortical areas in health and disease.
Contribution of TMS to the Study of Stroke Rehabilitation Diagnosis
One area in which TMS has contributed to the understanding of the neurobiological basis of motor disorders has been the evaluation and diagnosis of psychogenic paralysis. TMS may play a role by identifying normal MEPs and CMC, ruling out corticospinal tract neurophysiological damage, 69 and in investigating the nervous system mechanisms behind motor conversion disorder. 70 Liepert et al 70 reported decreased excitability during motor imagery in patients with this psychogenic paralysis. Such a finding may result in more objective diagnostic criteria for this disorder. Theoretically, a thorough characterization of neurophysiological abnormalities in this disorder may lead to interventions targeting these abnormalities and, hence, better treatment.
Prognosis
One of the major concerns in stroke rehabilitation is prognosis. Previous work demonstrated that high motor thresholds or a complete absence of MEPs in the paretic hand after subacute stroke are associated with poorer prognosis in terms of motor recovery. [71] [72] [73] On the other hand, the presence of MEPs, even with prolonged CMC time, may predict better prognosis. [72] [73] [74] [75] [76] [77] [78] Functional measurements of corticospinal integrity as provided by TMS can complement data on anatomical integrity as measured by diffusion tensor imaging. A recent report showed that consistent with the previous literature, paretic limb MEP presence predicted meaningful gains in chronic stroke patients receiving motor rehabilitation. 79 Within the subgroup of patients in whom MEPs could not be evoked in the paretic hand (theoretically predicting poor prognosis), functional outcome was poorer in patients with greater posterior internal capsule fiber disruption, as measured by diffusion tensor imaging. Using these methods together can fine-tune our ability to generate more accurate prognostic evaluations. 79 
Understanding Mechanisms of Motor Deficits
Using TMS as a complex probe into the neurophysiological underpinnings of motor function allows researchers to comment about specific mechanisms of behavior and plasticity. Application of these techniques to patients with impaired nervous systems will likely reveal more regarding the mechanisms of both injury and recovery after stroke. These measures have potential not only to improve diagnosis and prognosis as discussed above but, even more intriguingly, to reveal new unpredicted targets for therapy.
Primary motor cortex. One of the early intriguing findings in the application of TMS to stroke patients was the presence of ipsilateral MEPs within the paretic limb, 71, [80] [81] [82] [83] [84] which are otherwise rarely found in healthy subjects at rest. This also seemed to correlate with other measures of increased excitability in the contralesional M1. [85] [86] [87] Interestingly, ipsilateral MEPs have been reported more frequently in poorly recovered stroke patients, 71 a finding interpreted as indicating that contralesional facilitation of excitability may be a marker of poor gains. 80 Based on these reports, much interest was triggered in questions regarding to what extent alterations in excitability in contralesional M1 influence recovery of motor function in the paretic arm and what mechanisms may be involved. In subacute, severely paretic stroke patients, Liepert et al 88 reported decreased SICI in contralesional M1 as compared with age-matched controls, a finding replicated in more acute patients. 36, [89] [90] [91] [92] Also, decreases in SICI in ipsilesional M1 have been consistently reported in the literature, both in the acute and chronic periods after stroke. 37, 90, [93] [94] [95] When assessing changes longitudinally, it does seem that acute disinhibition may, especially contralesionally, normalize over time. 92, 96 However, how measures of intracortical inhibition or its changes correlate with function at any particular time point may be highly dependent on initial patient characteristics. 36, 92, 96 Another issue that is presently under investigation is the extent to which decreased inhibition in contralesional M1 is present in patients with both cortical and subcortical lesions, 36, 91 perhaps explaining the relative variance in reproducibility. 94, 95 Finally, intense scrutiny is necessary to determine how these electrophysiological abnormalities relate to previously reported abnormalities in metabolic activity of both the ipsilesional and contralesional hemispheres of patients with stroke. [97] [98] [99] [100] [101] [102] [103] [104] Beyond investigation of the local changes in excitability of both M1s in stroke patients, it should be kept in mind that functional recovery is likely related to changes in distributed neuronal networks rather than in individual regions. Studies have begun to investigate the alteration in transcallosal neurophysiology after stroke. IHI 10 between the 2 M1s is likely altered after stroke, possibly in a lesion-locationdependent manner. 105 Examining whether changes in IHI 10 and SICI after stroke may be related, Butefisch and colleagues 37 have shown that the attenuation of SICI in ipsilesional M1 is not accompanied by a change in resting IHI 10 from contralesional to ipsilesional M1. In contrast, disinhibition of contralesional M1 is accompanied but not completely correlated with a decrease in IHI 10 from ipsilesional to contralesional M1s. Together, these findings may imply that at rest, local modulation of inhibition within ipsilesional M1 is prominent. However, a thorough investigation of the resting interactions between SICI and IHI 10 , which has begun in healthy individuals, 40, 106 will need to be carried out in stroke patients at various time points and levels of recovery before more fundamental conclusions can be made. It should also be kept in mind that neurophysiological abnormalities may be more prominent when patients intend to use the paretic hand, rather than when they remain at rest.
Much of these basic cortical physiology measures have been most thoroughly examined at rest. Clearly, extending such measures to active behavior will add significant insight into poststroke mechanisms of paralysis. For example, the phenomenon of facilitation of M1 excitability by forceful or complex activity of the ipsilateral limb has been explored in the healthy brain. [106] [107] [108] [109] [110] [111] How modulations in SICI and IHI 10 and their interactions may contribute to this facilitation has also been investigated in healthy subjects. 106 An understanding of these interactions in stroke patients would raise the possibility that nonparetic limb activity could change the physiology of the ipsilesional M1, as proposed in neurorehabilitative interventions such as bilateral arm training 112 or mirror therapy. 113 However, with isometric force production, nonparetic arm activity in stroke patients does not lead to as much ipsilateral M1 facilitation as seen in healthy controls. 114, 115 Perhaps this lack of task-dependent modulation in ipsilesional M1 is because of abnormalities in IHI 10 after stroke. 116 Studies have begun to address this question by looking at premovement IHI 10 . In chronic, relatively well-recovered stroke patients, initially normal levels of IHI 10 from the contralesional to the ipsilesional M1 remain abnormally deep at the onset of paretic hand movement, in contrast to the disinhibition that accompanies nonparetic hand movement and movement in age-matched controls 117, 118 during a simple reaction time task (Figure 1) .
Expanding this line of research to encompass measures of both local and transcallosal neurophysiology and applying them to different motor tasks will allow us to more broadly characterize the neurophysiological underpinnings of motor deficits after stroke. Clearly, more work is required to fully elaborate these findings.
Nonprimary motor regions. Understanding that recovery processes are likely to rely on changes in neurophysiological interactions between different nodes in distributed networks led to the investigations of specific interregional interactions. Investigation of premotor cortex contributions to stroke recovery using TMS have revealed a role for both ipsilesional 119 and contralesional 103, 120 PMd cortices in the functioning of the paretic hand after stroke, with a trend toward contralesional PMd contributing more effectively in patients with more marked impairment, whereas ipsilesional PMd could be more active in patients with lesser impairment. A prominent possibility for translation of these findings will be investigations into how purposeful modulation of premotor cortical excitability may influence functional recovery after stroke.
The identification of neurophysiological abnormalities in patients with stroke is not an easy task. Technical challenges and heterogeneity in patients' characteristics make generalizations risky. Thus, careful manipulation of the various technical tools available is of the utmost importance. Ongoing investigations may flesh out the details regarding each technique and key parameters for subgroups of patients.
Understanding Mechanisms Underlying the Beneficial Effects of Intervention and Therapy
Just as TMS measurements can be used to investigate pathophysiology, they can also be used to gain insight into the mechanisms underlying the beneficial effects of therapeutic interventions. For example, using TMS measures of local inhibition and nonconcurrent fMRI (functional magnetic resonance imaging), Hamzei and colleagues 121 demonstrated in chronic subcortical stroke patients that functional improvement from constraint-induced therapy was accompanied by decreased fMRI activity and decreased SICI in the ipsilesional M1, whereas the opposite effects were found in patients with lesions in M1 or the corticospinal tract. This study suggested that the beneficial effects of constraint-induced therapy might be mediated at least partially by modulation of intracortical inhibition within ipsilesional M1, perhaps accompanied by some level of morphological changes as well. 122 We now know that the benefits of a single session of reaching practice in moderately impaired chronic stroke patients is accompanied by decreased transcallosal inhibition (ipsilateral CSP) 46 predominantly in the trained muscles, implying a specific and differential change in physiology that may contribute to the behavioral gains.
Attempts to enhance rehabilitation by applying different forms of noninvasive electrical and magnetic stimulation to the nervous system have increased. [123] [124] [125] [126] Interestingly, TMS can be used not only to carry out the stimulation but also to investigate the mechanisms by which it may be having its effects. For example, it was found that the beneficial effects of applying anodal transcranial direct current stimulation (tDCS) to ipsilesional M1 correlated with a decrease in SICI in this same cortical area. 126 Using an alternative approach, the beneficial effects of downregulating excitability in the contralesional M1 by cathodal tDCS were associated with normalization of the abnormal IHI 10 from the contralesional to the ipsilesional M1 (Hummel et al, personal communication, June 2009), perhaps contributing to clinically significant effects. [128] [129] [130] [131] TMS has also been used to evaluate the mechanisms underlying the beneficial effects of somatosensory input modulation in patients with chronic stroke. Specifically, the beneficial effects on paretic hand motor function caused by cutaneous anesthesia of the nonparetic hand are associated with decreased IHI 10 from contralesional to ipsilesional M1, which may be an underlying mechanism of action of the poststroke functional improvements seen with this and similar methods targeting the nonparetic limb, such as limb immobilization. 132 When applying somatosensory stimulation to a paretic hand in an attempt to facilitate motor function, [133] [134] [135] better baseline motor function correlated with deeper SICI in the contralesional hemisphere. 135 Also, behavioral gains in motor function induced by somatosensory stimulation of the paretic hand were accompanied by a reduction in SICI and SICF in the ipsilesional M1 in patients with chronic stroke. 135 As examination of the physiological mechanisms underlying the beneficial effects of therapeutic interventions has expanded, so has the desire to use measures such as surrogate markers. 137, 138 Although changes in TMS-measured cortical excitability and motor maps can be seen after various forms of neurorehabilitative treatments, [139] [140] [141] [142] [143] [144] [145] [146] and correlations can be found with various functional measures, there are significant hurdles to be managed before these measures become useful in the clinical setting. These measures need to be better standardized to make them consistent and easily reproducible across laboratories. 147 Such standardization would be an important step toward developing these measurements as useful markers of recovery. . Changes in activity of these networks after stroke. Ipsilesional short-interval intracortical inhibition (SICI) within M1 is decreased compared with the contralesional M1. At movement onset, interhemispheric inhibition at 10-millisecond interstimulus intervals (IHI 10 ) from contralesional to ipsilesional M1 is greater in the stroke brain than in the healthy brain. Whether this change in IHI 10 is caused by an increase in the transcallosal glutamatergic elements or ipsilesional inhibitory networks and how IHI 10 interacts with SICI in the stroke brain have yet to be elucidated.
Finally, one of the most sought out applications of TMS, as well as other noninvasive stimulation techniques like tDCS, is as an adjuvant strategy for rehabilitation of both motor 123 and cognitive 148 impairment after stroke, an issue that has been thoroughly reviewed recently.
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Conclusions and Future Directions
We have summarized the several ways in which TMS can be used to gain insight into the physiological mechanisms underlying motor deficits and neurorehabilitation after stroke, but no single technique alone provides a full mechanistic picture. Combinations of TMS with other techniques are bound to lead to a more sophisticated understanding. For instance, BDNF (brain-derived-neurotrophic-factor) has been implicated as an important biochemical modulator of neural plasticity, 150 and its relationship to physiology as measured by brain stimulation is beginning to be investigated, [151] [152] [153] although much less is known of its relation to motor learning. In addition, in vitro and nonhuman investigations of nervous system stimulation and physiology have great potential to elucidate some of the complexities that cannot be approached through human TMS work. 154, 155 Finally, though it has yet to be applied to stroke patients, concurrent TMS with various forms of metabolic functional imaging [156] [157] [158] and other neurophysiological measures 159 has potential to further elucidate changes in network connectivity after stroke and during rehabilitation. In summary, TMS represents a unique tool for probing the sophisticated physiological mechanisms underlying motor and nonmotor network activity mediating normal and impaired behavior after stroke and other brain lesions. From more sophisticated knowledge of the underlying physiology, more sophisticated and effective interventions may be derived and tested.
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